Danny Beales

NHS England will continue to encourage the wider adoption of drone technology in the National Health Service where it is both feasible and appropriate.

The NHS is committed to decarbonising travel and transport, with a clear vision of achieving a zero-emission fleet by 2040. In October 2023, NHS England published the NHS Net Zero Travel and Transport Strategy, which contains an ambitious, yet deliverable, roadmap to achieve this. Further information on the NHS Net Zero Travel and Transport Strategy is available at the following link:

https://www.england.nhs.uk/publication/net-zero-travel-and-transport-strategy/

This strategy includes drones as one of the interventions to achieve decarbonised travel and transport. There have already been a number of projects testing and implementing the use of drone technology in the NHS, including pathology drones in Cornwall and blood delivery drones in London. Further information on the pathology drones in Cornwall and the blood delivery drones in London is available, respectively, at the following two links:

https://www.rcpath.org/resource-report/pathology-drone-transport-hopes-to-overcome-logistical-constraints-in-cornwall.html

https://www.guysandstthomas.nhs.uk/news/nhs-delivery-drones-take-flight-offering-faster-and-greener-patient-care

Drones have also been used to deliver vital chemotherapy to the Isle of Wight, reducing a four-hour journey time by road and sea to a 30-minute flight, minimising waste and treatment delays whilst also reducing carbon, with further information available at the following link:

https://www.england.nhs.uk/greenernhs/whats-already-happening/drone-deliveries-of-vital-chemotherapy-to-the-isle-of-wight/

The medical drone delivery service for the Guy's and St Thomas' NHS Foundation Trust is a six-month trial, that started in November. There is potential for drones to support and improve the way the National Health Service delivers patient care, with the outcome of trials supporting NHS trusts to consider the benefits of adoption.

The Government is clear that patients should expect and receive the highest standard of service, and is determined to tackle the issue of corridor care.

Discussions on how to improve urgent and emergency care services are continuing, including how best to make use of data. Before the spring, we will set out the lessons learned from this winter and the improvements that we will put in place ahead of next winter.

Screening for prostate cancer is currently not recommended in the United Kingdom, due to the inaccuracy of the current best test Prostate Specific Antigen.

A UK National Screening Committee (UK NSC) review looking at whether to offer screening for prostate cancer is currently underway. This evidence review will cover modelling the clinical effectiveness and cost of several approaches to prostate cancer screening. This will include different potential ways of screening the whole population and targeted screening aimed at groups of people identified as being at higher-than-average risk, such as black men or men with a family history of cancer.

Once the modelling and evidence review are complete, it will be considered by the UK NSC. Subject to no further revisions being required, the UK NSC plans to look at the findings towards the end of 2025.

Further details of the UK NSC’s evidence review process are available at the following link:

https://www.gov.uk/government/publications/uk-nsc-evidence-review-process/uk-nsc-evidence-review-process

Shingles vaccination was originally routinely offered as part of the national immunisation programme to those aged 70, using the Zostavax vaccine. In 2019, the Joint Committee on Vaccination and Immunisation (JCVI) recommended that the programme should be changed to offer the Shingrix vaccine routinely at 60 years of age, that those aged between 60 and 70 years old should also be offered the vaccine, and that individuals would require two doses of Shingrix to complete the course.

Based on JCVI advice, the Department, the UK Health Security Agency and NHS England decided that the programme would be implemented in phases, with the first phase being that between 1 September 2023 and 31 August 2028, those who reach 65 or 70 years old should be called in on or after their 65th or 70th birthday. The second phase would be that from 1 September 2028 to 31 August 2033, those who reach age 60 or 65 years old should be called in on or after their 60th or 65th birthday. From 1 September 2033 onwards, vaccination will be routinely offered to those turning 60 years of age on or after their 60th birthday.

The JCVI also recommended that all severely immunosuppressed individuals aged 50 years old and older should be eligible for shingles vaccination due to their higher risk of complications from shingles. This programme change was also implemented on 1 September 2023. These individuals have been prioritised as part of the early roll-out of the programme to ensure those who are most vulnerable are protected.

Improving sexual health services is a priority for the Government and it is important that we capture the views of stakeholders as we develop our 10-Year Health Plan. To support this, we have launched a national engagement exercise. This will be the biggest conversation in the National Health Service’s history. We want to hear from a wide range of individuals and organisations, including many sexual health stakeholders. Organisations are encouraged to log onto the online portal and submit a response by 2 December 2024. The online portal is available at the following link:

https://change.nhs.uk/en-GB/

We have also published a Workshop in a Box that will support organisations to conduct their own local engagement activities. This is available from the community engagement tab on the abovementioned website from Monday 18 November 2024, with a request that partner organisations collate and upload their insights to the website by 14 February 2025.

NHS England have piloted sight testing and the dispensing of glasses in special schools since 2021. Between April 2021 and August 2024 a total of 23,832 sight tests were provided.

There were a total of 9,909 pairs of glasses issued between April 2021 and August 2024 as part of the service. Between April 2021 and March 2024, 859 sight tests were recorded with another sight problem identified, 14,048 sight tests were recorded where there was either no previous history or previous history was unknown and 6,083 sight tests were recorded where there was a history of hospital-based eye care.

The legislation that will underpin the roll out of this service across the country was laid on 28 November 2024.

NHS England have piloted sight testing and the dispensing of glasses in special schools since 2021. Between April 2021 and August 2024 a total of 23,832 sight tests were provided.

There were a total of 9,909 pairs of glasses issued between April 2021 and August 2024 as part of the service. Between April 2021 and March 2024, 859 sight tests were recorded with another sight problem identified, 14,048 sight tests were recorded where there was either no previous history or previous history was unknown and 6,083 sight tests were recorded where there was a history of hospital-based eye care.

The legislation that will underpin the roll out of this service across the country was laid on 28 November 2024.

Palliative care services are included in the list of services an integrated care board (ICB) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.

Whilst the majority of palliative and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at end of life and their loved ones.

The amount of funding each charitable hospice receives varies both within and between ICB areas. This will vary depending on demand in that ICB area but will also be dependent on the totality and type of palliative and end of life care provision from both NHS and non-NHS services, including charitable hospices, within each ICB area.

We, alongside key partners NHS England, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face, and we will consider next steps on palliative and end of life care, including funding, in the coming months.

Improving sexual health services is a priority for the Government and it is important that we capture the views of stakeholders as we develop our 10-Year Health Plan. To support this, we have launched a national engagement exercise. This will be the biggest conversation in the National Health Service’s history. We want to hear from a wide range of individuals and organisations, including many sexual health stakeholders. Organisations are encouraged to log onto the online portal and submit a response by 2 December 2024. The online portal is available at the following link:

https://change.nhs.uk/en-GB/

We have also published a Workshop in a Box that will support organisations to conduct their own local engagement activities. This is available from the community engagement tab on the abovementioned website from Monday 18 November 2024, with a request that partner organisations collate and upload their insights to the website by 14 February 2025.

Patients have been let down for too long whilst they wait for the care they need, including children awaiting hospital-based eyecare. The Government will ensure that 92% of patients return to waiting no longer than 18 weeks from Referral to Treatment (RTT) within our first term, a standard which has not been met consistently since September 2015. Outpatient services make up most of elective activity, so transforming outpatient services is a key part of our approach to cutting paediatric waiting times.

In 2023/24, the national mean average unit cost of an outpatient paediatric ophthalmology attendance without a procedure was £140, and the mean average national unit cost of a paediatric ophthalmology outpatient procedure was £248. In 2023/24, the median average waiting time for a first outpatient attendance for paediatric ophthalmology was 58 days, and the mean average waiting time was 97 days.

To supplement the student loan support provided by the Department for Education, the Department of Health and Social Care provides non-repayable and non-income assessed funding via the NHS Learning Support Fund. All eligible nursing students receive a grant of £5,000 per academic year. Additional funding of £1,000 per year is also available for those studying certain course, for example, Mental Health Nursing and Learning Disabilities Nursing, with a further £2,000 per year for childcare, as well as support for placement travel and accommodation costs. Students in exceptional hardship can also access up to a further £3,000 per year.

The following table shows the number of applicants, by the June deadline, to undergraduate nursing courses, for all domiciles, in England, each year from 2019 to 2024:

Source: published by the Universities and Colleges Admissions Service (UCAS), available at the following link:

https://www.ucas.com/undergraduate-statistics-and-reports/ucas-undergraduate-releases/applicant-releases-2024-cycle/2024-cycle-applicant-figures-30-june-deadline

Final applicant numbers for the 2024 cycle will be published by UCAS before the end of the year. The drop in nursing applicants follows the unprecedented demand for healthcare courses during the COVID-19 pandemic, and the number of applicants continues to outstrip the places on offer. Nursing training places are competitive, and lead to an attractive and important career in the National Health Service.

We are working closely with NHS England, universities, and UCAS to ensure that everyone who wants to pursue a rewarding healthcare career in nursing has the support and opportunities to do so.

The Government values nurses and is committed to supporting them as a profession, and in their everyday working lives. The Government accepted the pay recommendations of the NHS Pay Review Body for 2024/25 in full, providing a 5.5% consolidated pay uplift for 2024/25, backdated to 1 April, to approximately 1.4 million staff in England. A significant amount of work has also gone into developing a set of non-pay recommendations on measures to support the Agenda for Change workforce. This includes specific recommendations on improving career progression for the nursing workforce.

Targeted retention work for nurses and midwives is also being undertaken by NHS England and led by the Chief Nursing Officer. This includes the introduction of a nursing and midwifery retention self-assessment tool, a national preceptorship framework which provides early career support for nurses and midwives, and mentoring schemes.

It is essential that all National Health Service staff, including nurses, can work in a supportive and compassionate environment that recognises and prioritises health and wellbeing. NHS England has a wide-ranging package of mental health and wellbeing support for all staff.

The standard process confirming the total funding amount for major infrastructure projects involves review and approval of a Full Business Case. All trusts in the Programme have previously received indicative funding allocations to support planning, however these are commercially sensitive. The New Hospital Programme had confirmed £3.7 billion in funding up to the end of 2024/25.

Up to the end of 2023/24, the total amount received by The Hillingdon Hospital NHS Foundation Trust in funding for their new hospital schemes is £62.2 million.

The breakdown of how much the Trust received for their new hospital scheme is published annually as part of the Department’s Annual Reports and Accounts, with Public Dividend Capital to individual Trusts included in the Financial Assistance Report under section 40 of the National Health Service Act 2006. The 2022/23 report is available at the following link:

https://www.gov.uk/government/publications/dhsc-annual-report-and-accounts-2022-to-2023

The trust is currently developing their Outline Business Case for the new Hillingdon Hospital and is at Royal Institute of British Architects (RIBA) stage 2.

The standard process confirming the total funding amount for major infrastructure projects involves review and approval of a Full Business Case. All trusts in the Programme have previously received indicative funding allocations to support planning, however these are commercially sensitive. The New Hospital Programme had confirmed £3.7 billion in funding up to the end of 2024/25.

Up to the end of 2023/24, the total amount received by The Hillingdon Hospital NHS Foundation Trust in funding for their new hospital schemes is £62.2 million.

The breakdown of how much the Trust received for their new hospital scheme is published annually as part of the Department’s Annual Reports and Accounts, with Public Dividend Capital to individual Trusts included in the Financial Assistance Report under section 40 of the National Health Service Act 2006. The 2022/23 report is available at the following link:

https://www.gov.uk/government/publications/dhsc-annual-report-and-accounts-2022-to-2023

The trust is currently developing their Outline Business Case for the new Hillingdon Hospital and is at Royal Institute of British Architects (RIBA) stage 2.

The standard process confirming the total funding amount for major infrastructure projects involves review and approval of a Full Business Case. All trusts in the Programme have previously received indicative funding allocations to support planning, however these are commercially sensitive. The New Hospital Programme had confirmed £3.7 billion in funding up to the end of 2024/25.

Up to the end of 2023/24, the total amount received by The Hillingdon Hospital NHS Foundation Trust in funding for their new hospital schemes is £62.2 million.

The breakdown of how much the Trust received for their new hospital scheme is published annually as part of the Department’s Annual Reports and Accounts, with Public Dividend Capital to individual Trusts included in the Financial Assistance Report under section 40 of the National Health Service Act 2006. The 2022/23 report is available at the following link:

https://www.gov.uk/government/publications/dhsc-annual-report-and-accounts-2022-to-2023

The trust is currently developing their Outline Business Case for the new Hillingdon Hospital and is at Royal Institute of British Architects (RIBA) stage 2.

The standard process confirming the total funding amount for major infrastructure projects involves review and approval of a Full Business Case. All trusts in the Programme have previously received indicative funding allocations to support planning, however these are commercially sensitive. The New Hospital Programme had confirmed £3.7 billion in funding up to the end of 2024/25.

Up to the end of 2023/24, the total amount received by The Hillingdon Hospital NHS Foundation Trust in funding for their new hospital schemes is £62.2 million.

The breakdown of how much the Trust received for their new hospital scheme is published annually as part of the Department’s Annual Reports and Accounts, with Public Dividend Capital to individual Trusts included in the Financial Assistance Report under section 40 of the National Health Service Act 2006. The 2022/23 report is available at the following link:

https://www.gov.uk/government/publications/dhsc-annual-report-and-accounts-2022-to-2023

The trust is currently developing their Outline Business Case for the new Hillingdon Hospital and is at Royal Institute of British Architects (RIBA) stage 2.

As part of the Government's five long-term missions, we will launch a 10-Year Health Plan to reform the National Health Service and make it fit for the future. The plan will set out a bold agenda to deliver on the three big shifts needed, to move healthcare from the hospital to the community, from analogue to digital, and from sickness to prevention.

Improving health and good work outcomes for the 20 million people in the United Kingdom who live with musculoskeletal conditions, including arthritis, also forms a key part of the Government’s missions to kickstart economic growth, while building an NHS fit for the future. We will carefully be considering policies with input from the public, patients, health staff, and our stakeholders, as we develop the plan.

The NHS Car Parking Guidance 2022 includes mandatory and voluntary elements. All trusts that charge for hospital car parking provide free car parking to in-need groups, and are therefore compliant with the mandatory element of the NHS Car Parking Guidance 2022.

NHS England strongly encourages all trusts to follow the voluntary element of the guidance, particularly that where hospital car parking charges do exist, they should be reasonable for the area.

We are supporting NHS England in establishing a taskforce to look at attention deficit hyperactivity disorder (ADHD) service provision, and its impact on patient experience. The taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD and to help provide a joined-up approach in response to concerns around rising demand.

Alongside the work of the taskforce, NHS England will continue to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems which are trialling innovative ways of delivering ADHD services to ensure best practice is captured and shared across the system.